A novel form of treatment that encourages the body's own immune system to recognize and eliminate cancer cells in the brain has achieved success, according to research done in test animals.
The physiological reserves of elderly patients with cancer were evaluated and the most relevant biomarkers indicating their functional biological age were described in a recent publication by the Elderly Task Force of the European Organization for Research and Treatment of Cancer.
Inhibition of a molecule that occurs in some cancers with a poor prognosis as well as rheumatoid arthritis (RA) may lead to new treatments for both diseases.
Tumor cells with mutated p53, which is mutated in about half of all cancers, can be made much more vulnerable to chemotherapy by blocking another gene called MK2.
A new blood test for peptides cleaved by carboxypeptidase N may soon be available to help detect early stages of breast cancer.
The FDA approved obinutuzumab (Gazyva) or use in combination with chlorambucil to treat patients with previously untreated CLL, ibrutinib (Imbruvica) received FDA approval for the treatment of mantle cell lymphoma, and other FDA actions.
McMaster University researchers found no difference in patients with breast cancer who used simple compression bandages to treat lymphedema compared with those who underwent daily lymphatic massage.
The chemotherapy drug cyclophosphamide prevents graft-versus-host (GVHD) disease in people who receive bone marrow transplants through an immune system cell that evades the toxic effects of cyclophosphamide.
As cholesterol is metabolized, a potent stimulant of breast cancer is created—one that fuels estrogen receptor (ER)-positive breast cancers, according to new research.
Software that recognizes patterns in data is commonly used by scientists and economists. Now, researchers in the United States have applied similar algorithms to help them more accurately diagnose breast cancer.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|